ACE and congestive heart failure: Angiotensin receptor-neprilysin inhibitor (ARNI) reduced cardiovascular deaths and all-cause mortality compared with angiotensin-converting enzyme (ACE) inhibitors in patients with chronic heart failure and a reduced ejection fraction (HFrEF)11.